THE ANALOGY
Think of A2M as the barn manager.
Your demo crew showed up to clear out the old stalls. Great. But they're a little too enthusiastic — now they're swinging at the load-bearing beams. Someone needs to step in and say "easy, that one stays."
That's A2M's job inside your horse. It's a broad-spectrum protease inhibitor — meaning it grabs onto the enzymes that chew up cartilage and musculoskeletal tissue, and neutralizes them. It also binds inflammatory cytokines that drive ongoing damage.
“Healing isn't just about building. Half of it is knowing when to stop tearing things down.”
In a chronic joint or tendon problem, the breakdown signal often outruns the repair signal. A2M is part of how the body keeps that balance — and why it's a key target in regenerative therapy.
HOW IT WORKS IN THE HORSE
What A2M actually does at the injury site
Captures destructive enzymes
A2M binds matrix metalloproteinases (MMPs) and other proteases that break down cartilage and connective tissue, taking them out of circulation.
Neutralizes inflammatory signals
It also captures certain cytokines — molecular messengers that drive ongoing inflammation — interrupting cycles of chronic damage.
Supports tissue homeostasis
By keeping breakdown enzymes in check, A2M helps the body's repair processes actually finish the job instead of constantly fighting fresh damage.
A natural component of tissue homeostasis.
equicenta® CTM contains naturally occurring A2M — a component of normal tissue homeostasis — delivered as part of the complete umbilical-tissue matrix, not synthesized or concentrated in isolation.
Ask your veterinarian whether equicenta® CTM could be part of your horse's plan.
Every case is different. Your veterinarian is the right person to weigh whether a regenerative approach fits the diagnosis, the rehab plan, and your horse.
Talk to Our Team